Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven M Francque

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Therapeutic Advances in Endocrinology and Metabolism|November 29, 2021
NAFLD in type 1 diabetes: overrated or underappreciated?Jonathan Mertens, Luc F Van Gaal, Sven M Francque, et al.
Frontiers in Pharmacology|November 11, 2021
Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic HepatopathyJonathan Mertens, Christophe De Block, Maarten Spinhoven, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|May 29, 2004
Bilateral adrenal haemorrhage and acute adrenal insufficiency in a blunt abdominal trauma: a case-report and literature reviewSven M Francque, Veerle M Schwagten, Dirk K Ysebaert, et al.
Hepatology (Baltimore, Md.)|December 26, 2023
Metabolic dysfunction-associated steatotic liver disease and the heartStan Driessen, Sven M Francque, Stefan D Anker, et al.
Hepatology Communications|January 29, 2024
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitisSven M Francque, Alexander Hodge, Jerome Boursier, et al.
Frontiers in Immunology|February 22, 2019
The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and ObesityMikhaïl A Van Herck, Jonas Weyler, Wilhelmus J Kwanten, et al.
Diabetes, Obesity & Metabolism|June 26, 2024
Metabolic dysfunction-associated steatotic liver disease is associated with worse time in ranges in type 1 diabetesChloë Aernouts, Sarah P W Beldé, Julie Lambrechts, et al.
Acta Gastro-Enterologica Belgica|July 11, 2007
Fine needle trucut biopsy in focal liver lesions: a reliable and safe method in identifying the malignant nature of liver lesionsFilip F De Pauw, Sven M Francque, John-Paul J Bogers, et al.
Biomedicines|November 27, 2025
Prevalence and Risk Factors of MASLD in Prediabetes and Type 2 Diabetes Mellitus in Belgium and The NetherlandsLeen J M Heyens, Francesco Innocenti, Christophe Van Steenkiste, et al.
European Journal of Gastroenterology & Hepatology|September 17, 2004
Bacillus Calmette-Guérin-induced granulomatous hepatitis in a patient with a superficial bladder carcinomaSteven M Van Outryve, Sven M Francque, Paul A Gentens, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Therapeutic Advances in Endocrinology and Metabolism|November 29, 2021
NAFLD in type 1 diabetes: overrated or underappreciated?Jonathan Mertens, Luc F Van Gaal, Sven M Francque, et al.
Frontiers in Pharmacology|November 11, 2021
Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic HepatopathyJonathan Mertens, Christophe De Block, Maarten Spinhoven, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|May 29, 2004
Bilateral adrenal haemorrhage and acute adrenal insufficiency in a blunt abdominal trauma: a case-report and literature reviewSven M Francque, Veerle M Schwagten, Dirk K Ysebaert, et al.
Hepatology (Baltimore, Md.)|December 26, 2023
Metabolic dysfunction-associated steatotic liver disease and the heartStan Driessen, Sven M Francque, Stefan D Anker, et al.
Hepatology Communications|January 29, 2024
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitisSven M Francque, Alexander Hodge, Jerome Boursier, et al.
Frontiers in Immunology|February 22, 2019
The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and ObesityMikhaïl A Van Herck, Jonas Weyler, Wilhelmus J Kwanten, et al.
Diabetes, Obesity & Metabolism|June 26, 2024
Metabolic dysfunction-associated steatotic liver disease is associated with worse time in ranges in type 1 diabetesChloë Aernouts, Sarah P W Beldé, Julie Lambrechts, et al.
Acta Gastro-Enterologica Belgica|July 11, 2007
Fine needle trucut biopsy in focal liver lesions: a reliable and safe method in identifying the malignant nature of liver lesionsFilip F De Pauw, Sven M Francque, John-Paul J Bogers, et al.
Biomedicines|November 27, 2025
Prevalence and Risk Factors of MASLD in Prediabetes and Type 2 Diabetes Mellitus in Belgium and The NetherlandsLeen J M Heyens, Francesco Innocenti, Christophe Van Steenkiste, et al.
European Journal of Gastroenterology & Hepatology|September 17, 2004
Bacillus Calmette-Guérin-induced granulomatous hepatitis in a patient with a superficial bladder carcinomaSteven M Van Outryve, Sven M Francque, Paul A Gentens, et al.
Pageof 6